Sun Life Financial Inc. Common Stock vs Tilray Brands Inc — how do they compare? Sun Life Financial Inc. Common Stock trades at $77.62 (market cap $43.10B), while Tilray Brands Inc trades at $3.11 (market cap $481.79M). The key difference: Sun Life Financial Inc. Common Stock is far larger — about 89.5× Tilray Brands Inc's market cap, and Sun Life Financial Inc. Common Stock pays a 3.48% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Sun Life Financial Inc. Common Stock for 0 Days and Tilray Brands Inc for 31 Days on average.
| SLF | TLRY | |
|---|---|---|
Market Cap | $43.10B | $481.79M |
Volume | 448,420 | 4,056,443 |
Sector | Financials | Health |
52-Week High | $84.07 | $16.80 |
52-Week Low | $57.60 | $3.14 |
Typical Hold Time | 0 Days | 31 Days |
Enterprise Value | $44.83B | $635.71M |
Dividend Yield | 3.48% | — |
Signals from Pluang's Aura AI — not financial advice
Sun Life Financial (SLF) trades at $77.87, up 0.69% on the day, reflecting steady momentum. The stock shows consistent earnings beats in recent quarters, with Q3 2026 results pending. Financial health is solid, with a P/E of 18.82 and robust cash flow projections for 2026. Recent strategic moves include expanding disability benefits and forming a reinsurance partnership, signaling growth initiatives.
The outlook for SLF is cautiously optimistic, supported by earnings strength and strategic expansions. Key risks include competitive pressures and macroeconomic volatility. Analyst sentiment is mixed, with a majority hold rating, suggesting potential stability but limited near-term upside. Investors should weigh solid fundamentals against sector headwinds.
Tilray Brands (TLRY) trades at $3.27, down 2.68% on the day and near 52-week lows, with bearish technical signals dominating. The company reported $821 million in revenue for 2025 but posted a massive $2.19 billion net loss due to impairment charges. Recent earnings misses and negative cash flow from operations highlight ongoing profitability challenges despite analyst consensus pointing to significant upside potential.
TLRY presents a high-risk opportunity with substantial analyst price target divergence. While valuation metrics appear attractive (P/S 0.4x, P/B 0.3x), persistent losses and cash burn require careful monitoring. The stock's fate hinges on cannabis reform progress and the company's ability to achieve sustainable profitability amid competitive pressures.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Sun Life Financial Inc. is a Canada-based financial services company providing insurance, wealth and asset management, and health solutions for individuals and institutions. Its products span life, health, and disability insurance along with mutual funds and pension asset management, through operations in Canada, US, the United Kingdom, Ireland, and across Asia.
Read more on SLF →Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →